What you need to know about updated COVID vaccines following FDA approval

Key Points:

• The FDA has approved updated COVID-19 vaccines for the 2026-2027 season from Moderna, Pfizer, and Sanofi, targeting the XFG strain, a recombinant omicron variant currently responsible for about 40% of U.S. cases.
• Moderna's vaccine is authorized for individuals 6 months through 64 years with underlying conditions and all adults 65 and older, while Pfizer's is approved for those 5 years through 64 with underlying conditions and adults over 65.
• Vaccines will be available at pharmacies, hospitals, and clinics nationwide soon, and it is safe to receive COVID-19 vaccines simultaneously with flu or RSV vaccines.
• The CDC's previous free vaccine program for uninsured adults ended in August 2024, and while coverage by insurance plans including Medicare and Medicaid is expected, access for uninsured individuals this season remains uncertain.
• Experts emphasize vaccination to maintain protection against severe illness, especially for high-risk groups such as seniors, immunocompromised individuals, pregnant women, and very young children.